Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03312387 · ClinicalTrials.gov registry record · NA
Muscle, Essential Amino Acids, and eXercise in Heart Failure
A NA study, sponsored by Arizona State University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03312387 is a NA study that was terminated before completion, run by Arizona State University. The registered enrollment target is 1 participants.
The verdict
NCT03312387, a NA study, was terminated before completion, sponsored by Arizona State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Half of heart failure patients have preserved ejection fraction (HFpEF). Like patients with reduced ejection fraction (HFrEF), HFpEF patients suffer from exercise intolerance (low VO2max), which reduces physical function, quality of life, and survival. Strikingly, there is no medication proven to increase survival for HFpEF patients. Whereas exercise intolerance in HFrEF patients is the result of cardiovascular limitations, physical dysfunction in HFpEF patients is largely the result of peripheral abnormalities in skeletal muscle. Indeed, research in HFpEF patients identified that physical function and VO2peak are directly related to leg lean mass, and drugs focused on improving cardiovascular function have failed to improve VO2peak. Unfortunately, no therapy has been identified for this population that can concurrently improve cardiovascular and muscle health. The need for improved muscle therapies is reinforced by the fact that HFpEF patients are commonly older adults who are predisposed to muscle wasting. Strategic essential amino acid (EAA) ingestion has been shown to improve the adaptive response of muscle to exercise. Therefore, the investigators will determine, in HFpEF patients, the extent to which ingesting a strategic mixture of EAAs during an acute aerobic exercise training program enhances the response to this exercise strategy.
Interventions
- DIETARY_SUPPLEMENT Placebo
- OTHER Exercise
- DIETARY_SUPPLEMENT Essential Amino Acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-09-19 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03312387
The ClinicalTrials.gov registry entry for NCT03312387 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03312387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03312387 about?
NCT03312387 is a clinical study titled "Muscle, Essential Amino Acids, and eXercise in Heart Failure". Half of heart failure patients have preserved ejection fraction (HFpEF). Like patients with reduced ejection fraction (HFrEF), HFpEF patients suffer from exercise intolerance (low VO2max), which reduces physical function, quality of life, and survival. Strikingly, there is no medication proven to in...
What is the current status of trial NCT03312387?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-09-19. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03312387?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Exercise (OTHER), Essential Amino Acids (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03312387?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.